Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582231 · ClinicalTrials.gov registry record
Penile Injection Anxiety
A clinical trial of Erectile Dysfunction and Penile Injection Therapy, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 126
- Enrollment target
- 1
- Study location
NCT00582231 is a study of Erectile Dysfunction and Penile Injection Therapy that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 126 participants, below the 228-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00582231, a study of Erectile Dysfunction and Penile Injection Therapy, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to help us understand more about your experience with penile injection therapy. Many men become anxious when thinking about penile injections. We would like to understand more about this anxiety. You will be asked to fill out questionnaires before you start penile injection training, at each training visit, and then at your four month follow-up visit.
Conditions Studied
Interventions
- OTHER Questionnaires.
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2007-02 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582231
The ClinicalTrials.gov registry entry for NCT00582231 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 33 other Erectile Dysfunction trials with a reported enrollment target (45% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Erectile Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires. is the first listed.
NCT00582231 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00582231 about?
NCT00582231 is a clinical study titled "Penile Injection Anxiety". The purpose of this study is to help us understand more about your experience with penile injection therapy. Many men become anxious when thinking about penile injections. We would like to understand more about this anxiety. You will be asked to fill out questionnaires before you start penile inject...
What is the current status of trial NCT00582231?
This trial is currently active not recruiting. The enrollment target is 126 participants. The study started on 2007-02. Estimated completion is 2026-12.
What conditions does trial NCT00582231 study?
This clinical trial studies the following conditions: Erectile Dysfunction, Penile Injection Therapy, Radical Pelvic Surgery.
What interventions are being tested in trial NCT00582231?
The interventions under investigation include: Questionnaires. (OTHER).
Who is sponsoring clinical trial NCT00582231?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00582231 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Erectile Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
RECRUITING · NA
-
Double-S: a Wearable Device for Erectile Dysfunction
RECRUITING · NA
-
Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED
RECRUITING · NA
-
The Impact of Dietary Pattern on Erectile Function
RECRUITING · NA
-
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
RECRUITING · Phase 3
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.